Etopan 400 / 500 / XL 400 / XL 600 is a potent non-steroidal anti-inflammatory drug (NSAID) based on the active ingredient Etodolac. It is used in systemic therapy for acute and chronic inflammatory and degenerative conditions of the musculoskeletal system, providing effective relief from varying intensities of pain while reducing inflammation and swelling in joint tissues.

Application: Etopan is used for:

Treatment of osteoarthritis (osteoarthrosis)

Treatment of rheumatoid arthritis

Treatment of ankylosing spondylitis (Bekhterev’s disease)

Relief of acute pain conditions (including muscle, traumatic, and post-operative pain)

Management of severe pain during flare-ups of joint disorders

Reasons for use:

Acute and chronic arthritis of various origins

Degenerative joint changes (wear and breakdown of cartilage tissue)

Mild to moderate pain syndrome

Inflammatory processes in soft tissues and joints

Long-term pain management requirements in rheumatic conditions (for XL forms)

Properties:

Demonstrates strong anti-inflammatory activity

Provides powerful analgesic (pain-relieving) effects

Reduces morning stiffness in the joints

Helps improve and restore mobility in affected joints

The XL (Extended Release) line ensures controlled, long-lasting release of the active substance, reducing administration to once a day

Form of release:

Etopan 400 (Immediate release) — 400 mg tablets, immediate release, 30 pcs per pack.

Etopan 500 (Immediate release) — 500 mg tablets, immediate release, 20 pcs per pack.

Etopan XL 400 (Extended release) — 400 mg extended-release tablets, 20 pcs per pack.

Etopan XL 600 (Extended release) — 600 mg extended-release tablets, 20 pcs per pack.

Manufacturer: TARO Pharmaceutical Industries Ltd. (Israel)

Active substances:

Etodolac — 400 mg / 500 mg / 600 mg per single tablet

#Etopan #Etodolac #NSAID #PainRelief #AntiInflammatory #Arthritis #Arthrosis #Rheumatism #JointPain #JointTreatment #Taro #IsraelPharmacy #IsraeliMedicine #PainReliever #JointCare